Endocannabinoids in the immune system and cancer

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 66, Issue 2-3, 2002, Pages 319-332

  Parolaro, D ^a   Massi, P ^b   Rubino, T ^a   Monti, E ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; LIGAND; PALMIDROL; VANILLOID RECEPTOR; CANNABINOID; DRUG RECEPTOR; ENDOCANNABINOID; ICOSANOID;

APOPTOSIS; AUTOCRINE EFFECT; CANCER INHIBITION; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; MITOGENICITY; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; ANIMAL; BIOSYNTHESIS; CELL DIVISION; DRUG EFFECT; DRUG POTENTIATION; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CANNABINOIDS; CELL DIVISION; EICOSANOIDS; ENDOCANNABINOIDS; HUMANS; IMMUNE SYSTEM; NEOPLASMS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION;

EID: 0036019417     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2001.0355     Document Type: Article

References (108)

1. Identification of a functional relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation
2. 9-tetrahydrocannabinol in mouse spleen cells: A potential mechanism for cannabinoid-mediated immunosuppression
3. Cannabinoid-receptor expression in human leukocytes
4. Cannabinoid receptors CB1 and CB2: A characterization of expression and adenylate cyclase modulation within the immune system
5. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
6. Rat microglial cells express the peripheral-type cannabinoid receptor (CB2) which is negatively coupled to adenylyl cyclase
7. Expression of central and peripheral cannabinoid receptors in human immune tissue and leukocyte subpopulations
8. Molecular characterization of a peripheral receptor for cannabinoids
9. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and IL-2 expression in the murine T-cell line, EL4.IL-2
10. Attenuation of iNOS gene expression by delta-9-tetrahydrocannabinol is mediated through the inhibition of NF-κB/Rel activation
11. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
12. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signalling
13. Localization of cannabinoid receptors and nonsaturable high density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids
14. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes
15. Comparative biology of the endocannabioid system
16. 9-THC): A putative mechanism of cannabinoid-induced immune modulation
17. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and κB elements by cannabinol, a minimally CNS-active cannabinoid
18. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors
19. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor
20. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
21. A mutation in the second transmembrane region of the CB1 receptor selectively disrupts G protein signaling and prevents receptor internalization
22. The MAP kinase signal transduction pathway is activated by endogenous cannabinoid anandamide
23. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression
24. Activation by 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, of p42/44 mitogen-activated protein kinase in HL-60 cells
25. AP-1 activity is negatively regulated by cannabinol through inhibition of its protein components, c-fos and c-jun
26. Inhibition of adenylate cyclase by Δ-9-tetrahydrocannabinol in mouse spleen cells: A potential mechanism for cannabinoid-mediated immunosuppression
27. Role of nuclear factor of activated T-cells and activator protein-1 in the inhibition of interleukin-2 gene transcription by cannabinol in EL4 T-cells
28. Cannabinol-mediated inhibition of nuclear factor-kB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes
29. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by pertussis toxin-sensitive G-protein coupled mechanism
30. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells
31. Effects of CTx and 8-bromo-cAMP on LPS-induced gene expression of cytokines in murine peritoneal macrophages
32. Cyclic AMP is an essential factor in immune responses
33. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglia cells
34. The peripheral cannabinoid receptor: Adenylate cyclase inhibition and G protein coupling
35. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase
36. Anandamide and other N-acylethanolamines in mouse peritoneal macrophages
37. Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages
38. 18 neuroblastoma cells
39. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
40. Anandamide synthesis is induced by arachidonate mobilizing agonists in cells of the immune system
41. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes
42. Human mast cells take up and hydrolyze anandamide under the control of 5-lipoxygenase and do not express cannabinoid receptors
43. Activation of immune cell PAF receptor results in enhanced 2-arachidonoylglycerol synthesis
44. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages
45. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
46. Anandamide hydrolisis by human cells in culture and brain
47. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonoylethanolamide (anandamide): Their affinities for cannabinoid receptors and pathways of inactivation
48. Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis
49. Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes
50. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines
51. Anandamide, a natural ligand for the peripheral cannabinoid receptor is a novel synergistic growth factor for hematopoietic cells
52. Experimentally relevant levels of N-acylethanolamines including anandamide are present in serum-containing cell culture media
53. + cells
54. 9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells
55. Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells
56. 2-Arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrates immunocytes by cannabinoid receptor 1
57. Characterization of cannabinoid receptors in the spleen and in mast cells
58. Pharmacology of cannabinoid receptor ligands
59. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligand in HL-60 cells
60. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro
61. Effects of cannabinoid receptor ligands on LPS-induced pulmonary inflammation in mice
62. Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells
63. Inhibition of nitric oxide production in RAW264.7 macrophages by cannabinoids and palmitoylethanolamide
64. Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids
65. Antineoplastic activity of cannabinoids
66. The inhibition of DNA synthesis by cannabinoids
67. Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fisher rats and B6C3F1 mice
68. 9-tetrahydrocannabinol induces apoptosis in C6 glioma cells
69. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extra-cellular signal-regulated kinase activation
70. The CB1 cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase
71. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation
72. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells: Implications for cell proliferation and differentiation
73. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors
74. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide
75. Neuropeptide receptor status in human tumor cell lines
76. Suppression of Nerve Growth Factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
77. Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the antiproliferative effects of anandamide in human breast cancer cells
78. Anandamide induces apoptosis of PC-12 cells: Involvement of superoxide and caspase-3
79. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis
80. Failure of cannabinoid compounds to stimulate estrogen receptors
81. Unsaturated long chain N-acyl-vanillyl-amides (N-AVAMs): Vanilloid receptor ligands that inhibit anandamide facilitated transport and bind to CB1 cannabinoid receptors
82. 9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism
83. Selective activation of the CB2 receptor induces regression of gliomas in vivo
84. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway
85. 1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt
86. 9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes
87. Ceramide: A new second messenger of cannabinoid action
88. The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein FAN
89. Kinase suppressor of Ras is ceramide-activated protein kinase
90. Ceramide binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase
91. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis
92. Ceramide synthase mediates DNA-induced apoptosis: An alternative mechanism for generating death signals
93. L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: Role of inhibition of ceramide generation
94. De novo-synthesized ceramide signals apoptosis in astrocytes via extracellular signal-regulated kinase
95. The AMP-activated protein kinase prevents ceramide synthesis ex novo and apoptosis in astrocytes
96. Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation
97. 9-tetrahydrocannabinol
98. Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus
99. Functional CB1 cannabinoid receptors in human vascular endothelial cells
100. Cellular signal transduction by anandamide and 2-arachidonoylglycerol
101. Vanilloid (capsaicin) receptors and mechanisms
102. Interactions between synthetic vanilloids and the endogenous cannabinoid system
103. Anandamide: Some like it hot
104. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
105. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
106. Specific vanilloid responses in C6 rat glioma cells
107. Cannabinoids protect astrocytes from ceramide-induced apoptosis
108. Control of the cell survival/death decision by cannabinoids